Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Amortizatization of Intangibles: 2015-2025

Historic Amortizatization of Intangibles for ImmunityBio (IBRX) over the last 10 years, with Sep 2025 value amounting to $978,000.

  • ImmunityBio's Amortizatization of Intangibles rose 68.62% to $978,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 91.04%. This contributed to the annual value of $5.8 million for FY2024, which is 5.82% down from last year.
  • Latest data reveals that ImmunityBio reported Amortizatization of Intangibles of $978,000 as of Q3 2025, which was up 8,790.91% from $11,000 recorded in Q2 2025.
  • Over the past 5 years, ImmunityBio's Amortizatization of Intangibles peaked at $4.3 million during Q4 2024, and registered a low of $11,000 during Q2 2025.
  • For the 3-year period, ImmunityBio's Amortizatization of Intangibles averaged around $1.2 million, with its median value being $978,000 (2025).
  • In the last 5 years, ImmunityBio's Amortizatization of Intangibles skyrocketed by 3,555.56% in 2021 and then plummeted by 97.21% in 2025.
  • Quarterly analysis of 5 years shows ImmunityBio's Amortizatization of Intangibles stood at $1.4 million in 2021, then climbed by 19.36% to $1.7 million in 2022, then dropped by 19.73% to $1.3 million in 2023, then skyrocketed by 223.60% to $4.3 million in 2024, then spiked by 68.62% to $978,000 in 2025.
  • Its last three reported values are $978,000 in Q3 2025, $11,000 for Q2 2025, and $52,000 during Q1 2025.